openPR Logo
Press release

Postpartum Depression Drug Market 2018 intelligence by Players Sage Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Intas Pharmaceuticals Ltd., Mylan N.V., Anikem Laboratories, and Shionogi & Co

02-25-2019 11:39 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Postpartum Depression Drug

Postpartum Depression Drug

Increasing research activities for treatment of PPD is expected to propel growth of the postpartum depression drug market during the forecast period. For instance, Sage Therapeutics is undergoing phase 3 clinical study for the drug —Brexanolone, which might be useful in the treatment of PPD. The study started in May 2018 and is estimated to be completed in September 2020.

Furthermore, Marinus Pharmaceuticals, is undergoing clinical phase 2 study for the drug Ganaxolone in the treatment of PPD and other mood associated disorders. The clinical study started in June 2017 and is expected to be completed in June 2019.

Get Request a Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/2258

Antidepressant drugs refusals by the U.S. Food and Drug Administration (U.S FDA) are expected to be a major restraint in growth of the postpartum depression drug market over the forecast period. For instance, in April 2018, the U.S FDA refused New Drug Application of Alkermes plc.’s drug candidate ALKS 5461 which is to be administered orally. The drug could be useful in treating depressive disorders, which cannot be treated by other standard drug therapies. This refusal was due to failures in action of this oral medication.

On the basis of region, the global postpartum depression drug market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is estimated to hold dominant position in the global postpartum depression drug market during the forecast period, owing to increasing awareness of PPD.

For instance, annually, May 2017 is celebrated as a National Maternal Depression Awareness Month recognizing the seriousness of depression during and after pregnancy in the U.S. Furthermore, Asia Pacific is expected to witness significant growth in the global postpartum depression drug market during the forecast period, owing to increasing prevalence of PDD in the region. For instance, According to World Health Organization (WHO) July 2018 report, 22% of mothers in India suffer from PPD, annually.

Key players operating in the global postpartum depression drug market include, Sage Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Intas Pharmaceuticals Ltd., Mylan N.V., Anikem Laboratories, and Shionogi & Co., Ltd.

Download the PDF brochure @ www.coherentmarketinsights.com/insight/request-pdf/2258

Postpartum Depression Drug Market– Taxonomy

By Drug Class

Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Tricyclic Antidepressants
Atypical Antidepressants
Monoamine Oxidase Inhibitors (MAOIs)
Others
By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region

North America
Europe
Asia Pacific
Latin America
Middle East
Africa

About us

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postpartum Depression Drug Market 2018 intelligence by Players Sage Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Intas Pharmaceuticals Ltd., Mylan N.V., Anikem Laboratories, and Shionogi & Co here

News-ID: 1613607 • Views:

More Releases from Coherent Market Insights

Protocol Analyzer Market Unveiling the Future | Global Market Insights, Trends & Opportunities 2025-2032
Protocol Analyzer Market Unveiling the Future | Global Market Insights, Trends & …
The Protocol Analyzer market is estimated to be valued at USD 4.64 Bn in 2025 and is expected to reach USD 10.65 Bn by 2032, growing at a compound annual growth rate CAGR of 12.6% from 2025 to 2032. ➤ The latest report published by Coherent Market Insights highlights the growth prospects of the Protocol Analyzer Market from 2025 to 2032. In-depth research on Industry Size, Share, Business Analysis, Growth Factors,
Home Shopping Services Market is Going to Boom: Strategic Insights and Growth Opportunities with Key Players like Amazon.com, Inc. and eBay Inc.
Home Shopping Services Market is Going to Boom: Strategic Insights and Growth Op …
The Home Shopping Services market is estimated to be valued at USD 6.73 Bn in 2025 and is expected to reach USD 19.96 Bn by 2032, growing at a compound annual growth rate CAGR of 16.8% from 2025 to 2032. ➤ The Home Shopping Services Market Research Report covers a wide range of aspects, such as industry growth, revenue, development, segments, companies and progress, main trends, market dynamics, challenges, standards, deployment
Antibodies Contract Manufacturing Market Set for Dynamic Boom as Key Players Amgen Inc, Lonza Group, Celerion
Antibodies Contract Manufacturing Market Set for Dynamic Boom as Key Players Amg …
The Antibodies Contract Manufacturing market is estimated to be valued at USD 21.61 Bn in 2025 and is expected to reach USD 42.68 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032. ➤ The latest report "Antibodies Contract Manufacturing 2025 by Key Players, Regions, Types and Applications, Forecast to 2032" from Coherent Market Insights provides a detailed and comprehensive analysis of the Antibodies
Medical Marijuana Market Future Business Opportunities 2025-2032 | Tilray, Aphria Inc.
Medical Marijuana Market Future Business Opportunities 2025-2032 | Tilray, Aphri …
The Medical Marijuana market is estimated to be valued at USD 25.54 Bn in 2025 and is expected to reach USD 65.13 Bn by 2032, growing at a compound annual growth rate CAGR of 14.3% from 2025 to 2032. ➤ The market research report on the Medical Marijuana industry offers essential insights into growth trends and primary revenue drivers anticipated from 2025 to 2032. It delves into various factors influencing the

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase